Sign In
Buy IBIO
$1.84
+0.0800 (+4.55%)
At Close: Jun 03, 2026
iBio, Inc. (IBIO) CEO Tom Isett on Q2 2021 Results - Earnings Call Transcript
11:31pm, Tuesday, 16'th Feb 2021
iBio, Inc. (IBIO) CEO Tom Isett on Q2 2021 Results - Earnings Call Transcript
iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update
04:05pm, Tuesday, 16'th Feb 2021
BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its fina
7 Penny Stocks That Look Far Too Risky to Bet On
11:30am, Friday, 12'th Feb 2021
In the midst of an expensive market, traders are turning to penny stocks as a cheaper alternative. But avoid these seven risky penny names.
iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021
04:30pm, Tuesday, 09'th Feb 2021
BRYAN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that i
If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT
7 Stocks Under $10 to Buy for February
10:46am, Friday, 29'th Jan 2021
We may be seeing some sector rotation, and many companies that have made big moves in recent weeks have stocks under $10. The post 7 Stocks Under $10 to Buy for February appeared first on InvestorPl
IBIO Stock Price Increased 20.55%: Why It Happened
05:32pm, Saturday, 23'rd Jan 2021
The stock price of IBIO Inc (NYSEAMERICAN: IBIO) increased by 20.55%. This is why it happened.
Why iBio Stock Soared Today
02:02pm, Friday, 22'nd Jan 2021
One analyst says investors are underappreciating the biotech's growth prospects.
IBIO Stock Alert: Analyst Call Sends Shares of Pharma iBio Soaring
10:42am, Friday, 22'nd Jan 2021
Shares of IBIO stock are taking off on Friday after an analyst from Cantor Fitzgerald initiated an Overweight rating and $3 price target. The post IBIO Stock Alert: Analyst Call Sends Shares of Pharma
NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening
10:32am, Monday, 11'th Jan 2021
Phase 3 trial delays are pushing NVAX stock down, but the biotech still has a reliable vaccine candidate expected to generate $3.9 billion. The post NVAX Stock Is Worth a Small Position but Vaccine Ra
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
07:04am, Friday, 01'st Jan 2021
Innovation paid off big for investors.
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer
07:30am, Monday, 28'th Dec 2020
BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the ap
7 Stocks To Sell For A Fresh Start On New Year's Day
02:34pm, Thursday, 17'th Dec 2020
It's the time to clean house and make portfolio space for stronger investment opportunities during 2021. Here are 7 stocks to sell.
7 Penny Stocks With Further to Fall
05:11am, Thursday, 17'th Dec 2020
Value stocks are surging lately. That's caused many penny stocks to roar back to life.
iBio Announces Closing of its Public Offering of Common Stock
04:30pm, Thursday, 10'th Dec 2020
BRYAN, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the cl
